摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

p-iso-Butyl-oxy-benzoesaeure | 104097-41-8

中文名称
——
中文别名
——
英文名称
p-iso-Butyl-oxy-benzoesaeure
英文别名
4-sec-butoxy-benzoic acid;(+/-)-4-sec-Butyloxy-benzoesaeure;4-sec-Butoxy-benzoesaeure;4-[(1-methylpropyl)oxy]benzoic acid;4-Sec-butoxybenzoic acid;4-butan-2-yloxybenzoic acid
p-iso-Butyl-oxy-benzoesaeure化学式
CAS
104097-41-8
化学式
C11H14O3
mdl
MFCD01333527
分子量
194.23
InChiKey
LCMFDJQAHNDLEI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2918990090

SDS

SDS:df7fd8f18346fb9e87524131108f231d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    p-iso-Butyl-oxy-benzoesaeure4-(1,3-苯并噻唑-2-甲基)苯胺氯化亚砜碳酸氢钠 作用下, 以 乙醚 为溶剂, 反应 3.0h, 以34%的产率得到2-[4-(4-sec-butoxybenzamido)benzyl]benzothiazole
    参考文献:
    名称:
    Synthesis and In vitro Antimicrobial Activity of Novel 2-(4-(Substituted-carboxamido)benzyl / phenyl)benzothiazoles
    摘要:
    A new series of 2-[4-(4-substitutedbenzamido / phenylacetamido / phenylpropionamido) benzyl / phenyl]benzothiazole derivatives (6a-6w) were synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli with their drug-resistant isolates and a yeast Candida albicans. Microbiological results indicated that the compounds possessed a broad spectrum of activity against the tested microorganisms at MIC values between 200 and 6.25 mu g/ml. Compounds 6e and 6j exhibited the greatest activity with MIC values of 6.25 mu g/ml against Pseudomonas aeruginosa, and Staphylococcus aureus isolate, respectively.
    DOI:
    10.5562/cca2064
  • 作为产物:
    参考文献:
    名称:
    哌啶衍生物;从取代的哌啶醇衍生的局部麻醉剂。
    摘要:
    DOI:
    10.1021/ja01216a051
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS<br/>[FR] COMPOSÉS
    申请人:GLAXO GROUP LTD
    公开号:WO2009133136A1
    公开(公告)日:2009-11-05
    The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    这项发明涉及具有药理活性的新型噁二唑衍生物,其制备方法,含有它们的药物组合物以及它们在治疗各种疾病中的用途。
  • COMPOUNDS
    申请人:Eldred Colin David
    公开号:US20110039889A1
    公开(公告)日:2011-02-17
    The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    本发明涉及具有药理活性的新型噁唑啉衍生物,其制备方法,含有它们的制药组合物以及它们在治疗各种疾病中的应用。
  • Preparation of olefin polymerization catalyst component
    申请人:SHELL OIL COMPANY
    公开号:EP0292134A2
    公开(公告)日:1988-11-23
    Solid catalyst component for use in the polymerization of olefins and having improved activity and selectivity are prepared by: a) halogenating a magnesium compound containing at least one aryloxy, alkyl carbonate or alkyloxy group with a first halide of tetravalent titanium and a first electron donor; b₁) contacting the resulting halogenated product with a second halide of tetravalent titanium; and c) washing a resulting treated halogenated product with an inert hydrocarbon liquid, wherein a second electron donor is used in step a) or step b₁) and in that the product of step b₁) is contacted in step b₂ with a third halide of tetravalent titanium at a temperature of 40° to 140°C and thereafter the treated product is washed in step c).
    通过以下方法制备了用于烯烃聚合且活性和选择性得到改善的固体催化剂组分: a) 将含有至少一个芳氧基、碳酸烷基酯或烷氧基的化合物与四价的第一卤化物和 第一电子供体卤化; b₁) 将得到的卤化产物与四价的第二卤化物接触;以及 c) 用惰性烃类液体洗涤处理后的卤化产物,其中第二电子供体用于步骤 a) 或步骤 b₁),步骤 b₁)中的产物在步骤 b₂ 中与四价的第三卤化物在 40° 至 140°C 的温度下接触,然后在步骤 c) 中洗涤处理后的产物。
  • Propylene polymers and their production
    申请人:SHELL OIL COMPANY
    公开号:EP0320150A2
    公开(公告)日:1989-06-14
    An ultra high molecular melt flow rate propylene polymer in which the molecular weight distribution Q is not inversely proportional to the melt flow rate is produced, without post-reactor treatment, by contacting propylene and hydrogen, in the gas phase in the presence of a high activity catalyst.
    一种分子量分布 Q 与熔体流动速率不成反比的超高分子熔体流动速率丙烯聚合物,是在一种高活性催化剂存在下,通过气相中丙烯与氢的接触,在不进行反应后处理的情况下生产出来的。
  • Film for optical elements
    申请人:Nippon Mitsubishi Oil Corporation
    公开号:EP0982621A2
    公开(公告)日:2000-03-01
    A film for optical elements is formed by a liquid crystalline composition comprising the following components (a) and (b): (a) a liquid crystalline polymer which exhibits an optically positive uniaxial property; and (b) a polycyclic compound having a molecular weight of not more than 1,000 and wherein a plurality of alicyclic rings and/or aromatic rings are connected together through a linkage chain of 0 to 4 main-chain carbon atoms bonded to different ring carbon atoms, with hydrocarbon groups each having 1 to 20 carbon atoms being bonded respectively to both end rings through a linkage chain of 0 to 4 main-chain carbon atoms,    an orientation form formed in the state of liquid crystal of said liquid crystalline composition being fixed.
    用于光学元件的薄膜由液晶组合物形成,液晶组合物包括以下成分 (a) 和 (b): (a) 具有光学正单轴性的液晶聚合物;和 (b) 多环化合物,其分子量不超过 1,000,其中多个脂环和/或芳香环通过 0 至 4 个主链碳原子的连接链连接在一起,这些主链碳原子与不同的环碳原子键合,而每个具有 1 至 20 个碳原子的烃基通过 0 至 4 个主链碳原子的连接链分别与两个端环键合、 所述液晶组合物在液晶状态下形成的取向形式是固定的。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫